Explain the strategy
Support all 5 daughter companies within Stobbe Group in any possible way. To perform research, development, manufacturing, sales, services and supply pharmaceutical industry end-users, contractors and Process-Control-System (PCS) manufactures. With unmatched and advanced process equipment for mAbs expression, stem cell proliferation and viral vectors, plasmid and mRNA products.
Stobbe Group has one 100% share holder, no investors, no bank loans, no dept - and as to such we are simple to collaborate with. Since 2007 the investment in the portfolio became >30 mio Euro.
© 2022 Stobbe Pharma GmbH